Assembly Biosciences, Inc. (ASMB)

NasdaqGS • Currently down 0.31 (-1.38%) in today's trading session

Track congressional stock trades in Assembly Biosciences, Inc. (ASMB). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

Assembly Biosciences, Inc. is currently trading at $22.19, positioned at 15% of its 52-week range ($19.20 – $39.65).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$22.19
24h Change
-0.31 (-1.38%)
52 Week Range
$19.20–$39.65
View on NASDAQ

Assembly Biosciences, Inc. Price History and Technical Analysis

Congressional Trading Activity for ASMB

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$454.39M

Volume

480.92K

Beta

1.22

P/E Ratio

21.75

Fundamentals

EPS

$1.02

Div. Yield

-

Open

$22.22

Day Range

$21.98 – $22.78

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Jason A. Okazaki
IPO Date
2010-12-17

Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections within the United States. Its primary drug candidate,...

Earnings

Next Report

Q4 2026

18 Mar

EPS Est.

$2.75

Rev. Est.

$49.3M

Days Until

116

Recent Quarters

Q3 202612 Nov
EPS$-0.93
Miss 42.0%
Q3 20269 Nov
EPS-
Q2 202613 Aug
EPS$-0.20
Beat 72.4%
Q1 20267 May
EPS$-0.54
Beat 26.0%
Q4 202519 Mar
EPS$2.48
Beat 586.3%
Q3 202510 Nov
EPS$-0.72
Miss 44.0%
Q2 20256 Aug
EPS$-1.33
Miss 103.6%
Q1 20258 May
EPS$-1.17
Beat 41.8%
Q4 202420 Mar
EPS$-1.57
Beat 10.3%
Q3 20247 Nov
EPS$-1.51
Beat 25.3%
Q2 20248 Aug
EPS$-1.98
Beat 33.1%
Q1 20248 May
EPS$-1.66
Beat 39.4%
Q4 202327 Mar
EPS$-2.15
Beat 25.4%
Q3 20238 Nov
EPS$-3.24
Miss 17.4%
Q2 20239 Aug
EPS$-3.84
Miss 10.3%
Q1 20234 May
EPS$-4.44
Beat 0.0%
Q4 202222 Mar
EPS$-5.52
Beat 17.9%
Q3 20228 Nov
EPS$-5.76
Miss 2.1%
Q2 20229 Aug
EPS$-6.12
Miss 4.1%
Q1 202212 May
EPS$-5.76
Beat 2.0%
Q4 202110 Mar
EPS$-4.92
Beat 15.6%
Q3 20214 Nov
EPS$-4.92
Beat 25.4%
Q2 20215 Aug
EPS$-6.60
Beat 14.1%
Q1 20216 May
EPS$-8.28
Beat 12.7%
Q4 202025 Feb
EPS$-13.33
Miss 23.4%
Q3 20205 Nov
EPS$-1.08
Beat 88.5%
Q2 20205 Aug
EPS$2.28
Beat 733.3%
Q1 20207 May
EPS$-9.12
Beat 22.4%
Q4 20194 Mar
EPS$-11.88
Beat 2.0%
Q3 20197 Nov
EPS$-11.52
Miss 3.2%
Q2 20195 Aug
EPS$-8.64
Beat 34.6%
Q1 20199 May
EPS$-12.61
Beat 1.9%
Q4 201828 Feb
EPS$-12.36
Miss 13.2%
Q3 20188 Nov
EPS$-10.44
Beat 14.7%
Q2 20188 Aug
EPS$-15.61
Miss 44.5%
Q1 20187 May
EPS$-9.60
Miss 5.3%
Q4 20178 Mar
EPS$-1.92
Miss 143.0%
Q3 20171 Nov
EPS$-8.52
Beat 19.3%
Q2 20179 Aug
EPS$-9.36
Miss 1084.8%
Q1 20178 May
EPS$-9.72
Miss 2600.0%
Q4 20162 Mar
EPS$-8.04
Miss 1100.0%
Q3 20169 Nov
EPS$-8.04
Miss 1100.0%
Q2 20169 Aug
EPS$-7.08
Q1 201610 May
EPS$-7.68
Q4 201511 Mar
EPS$-5.40
Q3 20159 Nov
EPS$-4.56
Q2 201513 Aug
EPS$-4.92
Q1 20158 May
EPS$-0.64
Q4 201416 Mar
EPS$-4.56
Miss 700.0%
Q3 201417 Nov
EPS$-15.97
Miss 171.6%
Q2 201414 Aug
EPS$-6.24
Beat 5.5%
Q1 201414 May
EPS$-0.90
Miss 28.6%
Q1 20142 Apr
EPS$-1.45
Miss 3.6%
Q3 201312 Nov
EPS$-1.25
Beat 3.9%
Q2 20139 Aug
EPS$-1.20
Miss 20.0%
Q1 201310 May
EPS$-1.10
Beat 0.0%
Q4 201218 Mar
EPS$-1.40
Beat 9.1%
Q3 201213 Nov
EPS$-2.05
Miss 5.7%
Q2 20129 Aug
EPS$-2.95
Miss 2.1%
Q1 20127 May
EPS$-3.30
Miss 31.5%
Q4 201114 Mar
EPS$-8.90
Miss 64.2%
Q3 201114 Nov
EPS$-2.50
Beat 0.0%
Q2 201115 Aug
EPS$-4.85
Miss 90.2%
Q1 201116 May
EPS$-1.90
Miss 118.4%
Q2 201030 Sept
EPS$-19.85
Q1 201030 Jun
EPS$-23.78
Q4 200931 Mar
EPS$-22.58
Q3 200931 Dec
EPS$-18.07
Q2 200930 Sept
EPS$-10.47
Q1 200930 Jun
EPS$-6.61
Q4 200831 Mar
EPS$-15.59

No dividend data available for this stock.

Stock Splits

Split History

12 Feb 2024Reverse Split
Ratio1:12
14 Jul 2014Reverse Split
Ratio1:5

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.